Applied Filters
EU invests €35m into AI cancer diagnostics
The European Commission has pledged €35 million to promote the development of analysis of health images for cancer diagnostics, based on artificial intelligence.
EMA settles Brexit dispute; issues drug shortages guidance
The European Medicines Agency has ended a Brexit legal dispute over its Canary Wharf, London headquarters.
UKIPO seeks no-deal Brexit SPC comments
The UK Intellectual Property Office has today, July 5, opened a consultation into supplementary protection certificate law in the event of a ‘no deal’ Brexit.
CJEU rejects Viridis TM plea over MS drug
The Court of Justice of the European Union has rejected a trademark appeal submitted by Virgin Islands-headquartered Viridis Pharmaceutical.
Cancer Research UK partners with VC firm in $25m deal
Charity Cancer Research UK has united with SV Health Investors, a venture capital and growth equity firm, to develop new cancer medicines for patients.
Reddie & Grose adds new partner in Munich
Reddie & Grose has appointed Robin Ellis as a partner in the firm’s Munich office.
Carpmaels & Ransford name two new partners
Carpmaels & Ransford has appointed two life sciences attorneys as partners, effective yesterday, July 1.
SPC generics waiver comes into force
The controversial supplementary protection certificate manufacturing waiver has come into force today, July 1.
AbbVie to acquire Allergan for $63bn
US drug maker AbbVie has agreed to buy Allergan, the Ireland-headquartered maker of Botox, for $63 billion, in the latest blockbuster deal for the pharmaceutical industry.
English High Court refuses to grant Pfizer Arrow declaration
Pfizer’s attempt to secure an Arrow declaration in relation to its proposed launch of a cancer drug in Europe was shot down yesterday, June 20, by the English High Court.
